Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROSETTA: Sacral Neuromodulation vs Botox for Refractory Urge Urinary Incontinence
NCT01502956Phase 3Completed
- Sponsor
- Pelvic Floor Disorders Network
- Start
- Feb 2012
- Primary completion
- Jul 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in urge urinary incontinence (UUI), sponsored by Pelvic Floor Disorders Network. Started Feb 2012; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
urge urinary incontinence (UUI)
Beyond the preview
Go deeper on NCT01502956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01502956.